RO1NS118020 Research Supplements to Promote Diversity in Health-Related Research
RO1NS118020 促进健康相关研究多样性的研究补充剂
基本信息
- 批准号:10622090
- 负责人:
- 金额:$ 6.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAnabolismApplications GrantsBiochemicalCarrier ProteinsCellsCholineDNA MethylationDNA Modification ProcessDemyelinating DiseasesDevelopmentEpigenetic ProcessExhibitsFundingGene ExpressionGeneticHealthImpairmentLecithinLipidsMembraneMetabolismMolecularMyelinNeurogliaOligodendrogliaParentsPeripheralPhosphatidylinositolsPhospholipidsPositioning AttributeRegulationReportingResearchS-AdenosylmethionineSchwann CellsSignal TransductionTechniquesTestingTherapeuticbasecholine transporterdesigndisease prognosisearly onsetepigenetic regulationhistone methylationimprovedin vivoinsightmyelinationnervous system disorderparent grantpatient prognosisrepairedtool
项目摘要
ABSTRACT
Cells have a limited capacity to synthesize choline, thus cells depend on protein transporters to import
choline. Choline is used to synthesize phosphatidylcholine, from which structural lipid components of myelin are
synthesized. Phosphatidylcholine is also metabolized to generate phosphotidylinositols, whose phosphorylated
derivatives are important signaling lipids that regulate myelination. Choline is involved in synthesis of the
universal methyl donor, S-adenosylmethionine (SAM) for histone and DNA methylation, thus regulating gene
expression. Considering the position of choline at the crossroad for the biosynthesis of phospholipids and
epigenetic regulation, we have very little to no understanding of the regulation of choline import and choline-
dependent metabolism in myelinating glial cells. Choline transporters for myelin-forming glial cells have not been
identified.
We have identified choline-like-transporter 1 (CTL1) as an important regulator of Schwann cell myelination.
CTL1 deletion in Schwann cells (CTL1sc-KO) results in early onset of focal hyper-myelination in the PNS.
Biochemical analysis revealed an overall decrease in choline-derived phospholipids in the myelin. Furthermore,
CTL1 loss impaired myelin gene expression and exhibited altered DNA modifications in Schwann cells. Parent
grant proposal of this supplement test the hypothesis that CTL1 is a Schwann cell choline transporter. To that
end, we are currently testing three aims to determine: 1) whether CTL1 functions as a choline transporter in
Schwann cells, 2) whether CTL1 contributes to phosphatidylinositol signaling in the PNS and 3) whether CTL1
loss impact genetic and epigenetic profiles in Schwann cells.
Using the available tools and experimental techniques from the parent study, the proposed study in this
Research Supplement is designed to test the hypothesis that CTL1 functions as a choline transporter in
oligodendrocytes. This is based on previous reports and our recent findings that CTL1 is highly expressed in
oligodendrocytes and its expression increased during oligodendrocyte differentiation. Ms Adriana Torres, who
will be supported on the supplement funds, will carry on two specific aims that will determine 1) whether CTL1
functions as a choline transporter in oligodendrocytes and 2) whether CTL1-deficiency in vivo impacts
oligodendrocyte development and myelination. Results from the study are expected to provide important insights
into understanding the function of choline transport and its metabolism in myelin-forming glial cells.
摘要
细胞合成胆碱的能力有限,因此细胞依赖于蛋白质转运蛋白来输入
胆碱胆碱用于合成磷脂酰胆碱,髓鞘的结构脂质组分由磷脂酰胆碱合成。
合成了磷脂酰胆碱也被代谢以产生磷脂酰肌醇,其磷酸化
衍生物是调节髓鞘形成的重要信号脂质。胆碱参与合成
通用甲基供体,S-腺苷甲硫氨酸(SAM)用于组蛋白和DNA甲基化,从而调节基因
表情考虑到胆碱在磷脂生物合成的十字路口的位置,
表观遗传调控,我们对胆碱输入和胆碱-
在髓鞘形成的神经胶质细胞中依赖代谢。髓鞘形成神经胶质细胞的胆碱转运蛋白尚未被发现。
鉴定
我们已经确定胆碱样转运蛋白1(CTL 1)作为一个重要的调节许旺细胞髓鞘。
雪旺细胞中的CTL 1缺失(CTL 1 sc-KO)导致PNS中局灶性髓鞘形成的早期发作。
生化分析显示,在髓鞘胆碱衍生的磷脂的整体下降。此外,委员会认为,
CTL 1缺失损害髓鞘基因表达,并在雪旺细胞中表现出改变的DNA修饰。母
格兰特的建议,这一补充测试的假设,CTL 1是一个雪旺细胞胆碱转运。与
最后,我们目前正在测试三个目的,以确定:1)CTL 1是否作为胆碱转运蛋白在
雪旺细胞,2)CTL 1是否有助于PNS中的磷脂酰肌醇信号传导和3)CTL 1是否
损失影响雪旺细胞的遗传和表观遗传谱。
使用现有的工具和实验技术,从母研究,拟议的研究在此
研究补充旨在测试CTL 1作为胆碱转运蛋白的假设,
少突胶质细胞这是基于以前的报道和我们最近的发现,即CTL 1在
在少突胶质细胞分化过程中,其表达增加。Adriana托雷斯女士
将得到补充资金的支持,将进行两个具体目标,这将决定1)CTL 1
在少突胶质细胞中作为胆碱转运蛋白发挥作用,2)体内CTL 1缺乏是否影响
少突胶质细胞发育和髓鞘形成。这项研究的结果预计将提供重要的见解
了解胆碱转运及其代谢在髓鞘形成神经胶质细胞中的功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAESUN A KIM其他文献
HAESUN A KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAESUN A KIM', 18)}}的其他基金
Choline-dependent metabolism in PNS myelination
PNS 髓鞘形成中的胆碱依赖性代谢
- 批准号:
10033698 - 财政年份:2020
- 资助金额:
$ 6.22万 - 项目类别:
Choline-dependent metabolism in PNS myelination
PNS 髓鞘形成中的胆碱依赖性代谢
- 批准号:
10412131 - 财政年份:2020
- 资助金额:
$ 6.22万 - 项目类别:
Choline-dependent metabolism in PNS myelination
PNS 髓鞘形成中的胆碱依赖性代谢
- 批准号:
10913670 - 财政年份:2020
- 资助金额:
$ 6.22万 - 项目类别:
Choline-dependent metabolism in PNS myelination
PNS 髓鞘形成中的胆碱依赖性代谢
- 批准号:
10626009 - 财政年份:2020
- 资助金额:
$ 6.22万 - 项目类别:
Choline-dependent metabolism in PNS myelination
PNS 髓鞘形成中的胆碱依赖性代谢
- 批准号:
10247043 - 财政年份:2020
- 资助金额:
$ 6.22万 - 项目类别:
Mucolipin-1-Mediated Mechanisms of Neuronal Clearance in Alzheimer’s Disease
Mucolipin-1 介导的阿尔茨海默病神经元清除机制
- 批准号:
10083388 - 财政年份:2019
- 资助金额:
$ 6.22万 - 项目类别:
Impact of mechanical injury on oligodendrocyte myelin homeostasis in adult brain
机械损伤对成人大脑少突胶质细胞髓鞘稳态的影响
- 批准号:
9769889 - 财政年份:2018
- 资助金额:
$ 6.22万 - 项目类别:
Functional analysis of erbB2 signaling in myelin-forming glial cells
髓鞘形成神经胶质细胞中 erbB2 信号的功能分析
- 批准号:
7643209 - 财政年份:2008
- 资助金额:
$ 6.22万 - 项目类别:
Functional analysis of erbB2 signaling in myelin-forming glial cells
髓鞘形成神经胶质细胞中 erbB2 信号的功能分析
- 批准号:
8033252 - 财政年份:2008
- 资助金额:
$ 6.22万 - 项目类别:
Functional analysis of erbB2 signaling in myelin-forming glial cells
髓鞘形成神经胶质细胞中 erbB2 信号的功能分析
- 批准号:
7523849 - 财政年份:2008
- 资助金额:
$ 6.22万 - 项目类别:
相似海外基金
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10590611 - 财政年份:2022
- 资助金额:
$ 6.22万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
- 批准号:
10706006 - 财政年份:2022
- 资助金额:
$ 6.22万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10368975 - 财政年份:2021
- 资助金额:
$ 6.22万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10365254 - 财政年份:2021
- 资助金额:
$ 6.22万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10202896 - 财政年份:2021
- 资助金额:
$ 6.22万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10531570 - 财政年份:2021
- 资助金额:
$ 6.22万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10541847 - 财政年份:2019
- 资助金额:
$ 6.22万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10319573 - 财政年份:2019
- 资助金额:
$ 6.22万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10062790 - 财政年份:2019
- 资助金额:
$ 6.22万 - 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
- 批准号:
DE170100628 - 财政年份:2017
- 资助金额:
$ 6.22万 - 项目类别:
Discovery Early Career Researcher Award